0001012975-18-000006.txt : 20180102 0001012975-18-000006.hdr.sgml : 20180102 20180102170950 ACCESSION NUMBER: 0001012975-18-000006 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20171228 FILED AS OF DATE: 20180102 DATE AS OF CHANGE: 20180102 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SCHAFFER DERACE L CENTRAL INDEX KEY: 0001031735 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090] STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-32587 FILM NUMBER: 18502553 MAIL ADDRESS: STREET 1: C/O ALLION HEALTHCARE, INC. STREET 2: 1660 WALT WHITMAN ROAD, SUITE 105 CITY: MELVILLE STATE: NY ZIP: 11747 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Altimmune, Inc. CENTRAL INDEX KEY: 0001326190 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 202726770 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 19 FIRSTFIELD ROAD CITY: GAITHERSBURG STATE: MD ZIP: 20878 BUSINESS PHONE: 2406541450 MAIL ADDRESS: STREET 1: 19 FIRSTFIELD ROAD CITY: GAITHERSBURG STATE: MD ZIP: 20878 FORMER COMPANY: FORMER CONFORMED NAME: PHARMATHENE, INC DATE OF NAME CHANGE: 20071016 FORMER COMPANY: FORMER CONFORMED NAME: HEALTHCARE ACQUISITION CORP DATE OF NAME CHANGE: 20050505 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2017-12-28 0001326190 Altimmune, Inc. ALT 0001031735 SCHAFFER DERACE L C/O ALTIMMUNE, INC. 19 FIRSTFIELD ROAD, SUITE 200 GAITHERSBURG MD 20878 1 0 0 0 Common Stock, par value $0.0001 2017-12-28 4 P 0 58711 1.9191 A 550754 D Common Stock, par value $0.0001 2017-12-29 4 P 0 38699 1.9323 A 589453 D Common Stock, par value $0.0001 12393 I IRA The price reflected is the weighted-average purchase price for shares purchased. The range of purchase prices for the transactions reported was $1.76 to $2.00 per share. The Reporting Person undertakes to provide, upon request by the Issuer, any security holder of the Issuer, or the SEC staff, full information regarding the number of shares purchased at each separate price. The price reflected is the weighted-average purchase price for shares purchased. The range of purchase prices for the transactions reported was $1.90 to $1.98 per share. The Reporting Person undertakes to provide, upon request by the Issuer, any security holder of the Issuer, or the SEC staff, full information regarding the number of shares purchased at each separate price. /s/ Ori Solomon, Attorney in fact for Derace Schaffer 2018-01-02